United States Food and Drug Administration clinical trial of the Implantable Collamer Lens (ICL) for moderate to high myopia: three-year follow-up.

Purpose: To report on 3-year postoperative safety and efficacy outcomes with the Myopic Implantable Collamer Lens (ICL).

Design: Prospective nonrandomized clinical trial.

Participants: Five hundred twenty-six eyes of 294 patients with between 3.

U.S. Food and Drug Administration clinical trial of the Implantable Contact Lens for moderate to high myopia.

Purpose: To assess the safety and efficacy of the Implantable Contact Lens (ICL) to treat moderate to high myopia.

Design: Prospective nonrandomized clinical trial.

Participants: Five hundred twenty-three eyes of 291 patients with between 3 and 20.